The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...
Follicle-stimulating hormone (FSH), a glycoprotein secreted by gonadotroph cells of the anterior pituitary, is classically ...
GlobalData on MSN
Dewpoint receives FDA orphan drug designation for DPTX3186
The ODD programme incentivises the development of medicines for conditions affecting fewer than 200,000 individuals in the US ...
US biotech Dewpoint Therapeutics has announced that the US Food and Drug Administration (FDA) has granted Orphan Drug ...
NMRA-898 is structurally distinct from NMRA-861 and is the second M4 PAM in Neumora’s M4 franchise; both programs have potential best-in-class pharmacology No convulsions observed in pre-clinical ...
Aldeyra has since resubmitted its application, buffing it up with a “single clinical trial that achieved the primary endpoint ...
IND opening marks culmination of partnership between Dewpoint and Evotec, advancing a de novo development candidate through ...
The program in question is Neuphoria’s BNC210, also known as soclenicant, an α7 nicotinic receptor negative alteration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback